Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- Agriculture
- Manufacturing, Other
- University / Academia / Research
- Food and Beverage
- Defense
- Air and Climate
- Soil and Groundwater
- Energy
- Banking & Finance / Insurance / Legal
- Electronics and Computers
- Aerospace & Air Transport
- Retail
- Packaging
- Plastics & Resins
- Waste and Recycling
- Oil, Gas & Refineries
- Water and Wastewater
- Government
- Construction & Construction Materials
Clinical Development Suppliers & Manufacturers
477 companies found
Premium
based inPlainsboro, DELAWARE (USA)
Our Raman spectrometers are used every day in applications that demand fast, reliable, and accurate material identification—whether in the classroom, in the lab, on the production floor, or out in the field. From quality control in pharma to ...
SAVANNAH is Metrohm's most compact OEM Raman module. The SAVANNAH is equipped with an integrated 785nm laser and a high-performance spectrograph. SAVANNAH comes with a command set for data acquisition and data transfer through USB or UART ...
based inBoldon Colliery, UNITED KINGDOM
Immunodiagnostic Systems Holdings Ltd (hereafter referred to as IDS) is a leading in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays and automated immunoanalyser ...
based inBerlin, GERMANY
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We ...
Natural Killer (NK) cell mediated tumor cell killing is one prominent mode of action for anti-cancer or anti-infectious antibodies. It relies on the antibody´s ability to recruit NK cells, which is enhanced when the antibody Fc glycan is ...
based inCarlsbad, CALIFORNIA (USA)
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous cells but not in normal adult cells. VAC2, which is produced from our ...
based inCambridge, MASSACHUSETTS (USA)
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with ...
The first patient was dosed with our investigational genome editing treatment for transthyretin (ATTR) amyloidosis in November 2020. Our modular approach enables us to optimize the power and versatility of the CRISPR/Cas9 technology and, ...
based inSouth San Francisco, CALIFORNIA (USA)
We are building the next enduring biotechnology company of the digital age. Verge has pioneered the industry's most advanced all-in-human, artificial intelligence powered drug discovery platform to unlock new drugs at scale for the biggest medical ...
based inDoylestown, PENNSYLVANIA (USA)
Incorporated in PA in 2011, our MISSION is to translate our circulating cell-free DNA (cfDNA) in urine technology into improved cancer screening and management by liquid biopsy towards our VISION of decreased global cancer mortality. Our proprietary ...
based inOss, NETHERLANDS
BioConnection is one of the first European CMOs to provide sterile production facilities as well as expertise for small/ medium sized (bio)pharmaceutical companies. With BioConnection you have access to aseptic production of small-scale clinical ...
based inColumbus, OHIO (USA)
Deep Lens is a digital healthcare company focused on a groundbreaking approach to faster recruitment of the best-suited cancer patients to clinical trials. VIPER, Deep Lens’ integrated cloud platform, provides care teams with visibility and ...
VIPER is a unique patient recruitment tool specifically designed to inform and educate care teams of potential trial participants earlier than alternative methods through optimizing their enrollment process and not allowing patients to slip through ...
based inShirley, NEW YORK (USA)
CD BioSciences is committed to fulfilling all your demands in the research of signaling pathways. We provide high-quality reagents, one-stop services and comprehensive solutions to support your innovative discoveries. Our mission is to provide our ...
based inKAARINA, FINLAND
Labmaster Oy Ltd. is a company engaged in the design, development, and manufacturing of various products, ensuring they meet specified criteria through proper storage, usage, and transportation guidelines. They emphasize adherence to instructions ...
based inRedwood City, CALIFORNIA (USA)
Our Clinical Operations Oversight Solution ClinOps Pro, simplifies clinical trial oversight by consolidating inputs from all data sources and efficiently producing accurate, updated dashboards and trackers to facilitate critical decision ...
based inAlbano Laziale, ITALY
GINEVRI is an independent company focused on the manufacture of advanced medical equipment and solutions for Neonatal Care. The Company has many years of experience of experience, since 1954, concerning the complex and innovative requirements of ...
based inBoston, MASSACHUSETTS (USA)
At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective ...
AISightTM is a web-based digital pathology slide viewing platform that enables the management and analysis of whole slide ...
based inSunrise, FLORIDA (USA)
U.S. Stem Cell, Inc. (OTC:USRM) is an emerging leader in the worldwide development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions. Based in Sunrise, Florida, the Company has developed a clinical ...
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
based inWatertown, MASSACHUSETTS (USA)
Lyra Therapeutics is a clinical-stage company developing medicines precisely designed to target ear, nose and throat (ENT) diseases. Our goal is to transform the ENT treatment paradigm by providing effective solutions for physicians and new ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major ...
based inStockholm, SWEDEN
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic ...
The human recombinant protein GAD65 is manufactured in insect cells in a well-controlled GMP process. The manufacturing process is developed for late phase clinical use. A new manufacturing facility is being set up ...
based inLausanne, SWITZERLAND
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug ...
Oxaliplatin is a diaminocyclohexane (DACH) platin. It is the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®, which has dramatically changed the prognosis of colorectal cancer. In 1996, prior to the introduction ...
